Rhode Island Hospital at Brown University Health will receive $1 million to demonstrate proof of concept for a test that uses RNA sequencing to detect bacterial pneumonia from whole blood.
A BD exec said supplier manufacturing problems are behind the disruption and that more supplies should become available in September.
Diagnostics and health technology company Scout say its test can detect gonorrhea infections in 30 minutes, at less than half the cost of other options.
The tool holds promise for increasing efficiency in clinic settings and promoting antibiotic stewardship.
The results of a randomized trial suggests rapid syndromic PCR tests could complement or replace culture-based diagnostic methods for pneumonia.
The portable test from Visby Medical will be able to detect gonorrhea and assess susceptibility to ciprofloxacin.
The funding will support a project to develop diagnostic platforms that can detect drug-resistant infections and identify the right antibiotic in real time.
Lumos Diagnostics receives FDA clearance for a test that helps to determine when antibiotics are needed for respiratory infections.
A randomized controlled trial in Vietnam finds that the use of point-of-care C-reactive protein testing reduced antibiotic prescribing.
The recipients are Vedanta Biosciences, whose lead candidate is a microbiome-directed C difficile therapy, and diagnostics company Pattern Bioscience for rapid bacterial susceptibility tests.
